Lazo-Langner A - Search Results

1

Erythropoiesis-stimulating agents in elderly patients with anemia: response and cardiovascular outcomes.

Gowanlock Z, Sriram S, Martin A, Xenocostas A, Lazo-Langner A. Gowanlock Z, et al. Blood Adv. 2017 Aug 17;1(19):1538-1545. doi: 10.1182/bloodadvances.2017007559. eCollection 2017 Aug 22. Blood Adv. 2017. PMID: 29296795 Free PMC article.

2

The risk of dialysis access thrombosis is related to the transforming growth factor-beta1 production haplotype and is modified by polymorphisms in the plasminogen activator inhibitor-type 1 gene.

Lazo-Langner A, Knoll GA, Wells PS, Carson N, Rodger MA. Lazo-Langner A, et al. Blood. 2006 Dec 15;108(13):4052-8. doi: 10.1182/blood-2006-06-028902. Epub 2006 Aug 24. Blood. 2006. PMID: 16931622 Free article. Clinical Trial.

3

Predictors of unsuccessful mobilization with granulocyte colony-stimulating factor alone in patients undergoing autologous hematopoietic stem cell transplantation.

Chow S, Lazo-Langner A, Ormond G, Howson-Jan K, Xenocostas A. Chow S, et al. J Clin Apher. 2013 Aug;28(4):285-92. doi: 10.1002/jca.21252. Epub 2013 Feb 21. J Clin Apher. 2013. PMID: 23426584

4

Patient preferences for stopping tyrosine kinase inhibitors in chronic myeloid leukemia.

Sanford D, Kyle R, Lazo-Langner A, Xenocostas A, Chin-Yee I, Howson-Jan K, Hsia C. Sanford D, et al. Curr Oncol. 2014 Apr;21(2):e241-9. doi: 10.3747/co.21.1736. Curr Oncol. 2014. PMID: 24764709 Free PMC article.

5

Response to "Need to minimize bias when surveying patient attitudes to stopping cml treatment".

Sanford D, Kyle R, Lazo-Langner A, Xenocostas A, Chin-Yee I, Howson-Jan K, Hsia CC. Sanford D, et al. Curr Oncol. 2014 Dec;21(6):e803-4. doi: 10.3747/co.21.2200. Curr Oncol. 2014. PMID: 25489271 Free PMC article. No abstract available.

6

Erythropoietin in anemia of unknown etiology: A systematic review and meta-analysis.

Sriram S, Xenocostas A, Lazo-Langner A. Sriram S, et al. Hematology. 2016 May;21(4):234-40. doi: 10.1080/10245332.2015.1101972. Epub 2016 Jan 8. Hematology. 2016. PMID: 26747131 Free article. Review.

7

Risk factors predictive of occult cancer detection in patients with unprovoked venous thromboembolism.

Ihaddadene R, Corsi DJ, Lazo-Langner A, Shivakumar S, Zarychanski R, Tagalakis V, Solymoss S, Routhier N, Douketis J, Le Gal G, Carrier M. Ihaddadene R, et al. Blood. 2016 Apr 21;127(16):2035-7. doi: 10.1182/blood-2015-11-682963. Epub 2016 Jan 27. Blood. 2016. PMID: 26817957 Free PMC article. Clinical Trial.

8

Randomized double-blind safety comparison of intravenous iron dextran versus iron sucrose in an adult non-hemodialysis outpatient population: A feasibility study.

Louzada ML, Hsia CC, Al-Ani F, Ralley F, Xenocostas A, Martin J, Connelly SE, Chin-Yee IH, Minuk L, Lazo-Langner A. Louzada ML, et al. BMC Hematol. 2016 Mar 11;16:7. doi: 10.1186/s12878-016-0046-8. eCollection 2016. BMC Hematol. 2016. PMID: 26973791 Free PMC article.

9

Erythropoietin Levels in Elderly Patients with Anemia of Unknown Etiology.

Gowanlock Z, Sriram S, Martin A, Xenocostas A, Lazo-Langner A. Gowanlock Z, et al. PLoS One. 2016 Jun 16;11(6):e0157279. doi: 10.1371/journal.pone.0157279. eCollection 2016. PLoS One. 2016. PMID: 27310832 Free PMC article.

10

Adherence to, and outcomes of, a galactomannan screening protocol in high-risk hematology patients.

Harricharan S, Biederman K, Bombassaro AM, Lazo-Langner A, Elsayed S, Fulford A, Delport JA, Xenocostas A. Harricharan S, et al. Curr Oncol. 2018 Apr;25(2):e139-e145. doi: 10.3747/co.25.3848. Epub 2018 Apr 30. Curr Oncol. 2018. PMID: 29719438 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

156 results

Search Page

Filters